These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24104195)

  • 1. Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
    Kornej J; Potpara T; Lip GY
    Pol Arch Med Wewn; 2013; 123(11):623-34. PubMed ID: 24104195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Banerjee A; Lane DA; Torp-Pedersen C; Lip GY
    Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B; Faille D; Ajzenberg N
    Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
    John A; Michel MS
    Urologe A; 2014 Jun; 53(6):893-902; quiz 903. PubMed ID: 24845012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stroke prevention in atrial fibrillation : old and new anticoagulants].
    Darius H; Sommer S
    Herz; 2013 May; 38(3):231-8. PubMed ID: 23632424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP; Halperin JL
    Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of patients on new oral anticoagulants.
    Lai A; Davidson N; Galloway SW; Thachil J
    Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
    Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stroke prevention after stroke in patients with atrial fibrillation: a case-based review].
    Kovács T
    Orv Hetil; 2014 Oct; 155(42):1655-60. PubMed ID: 25305723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all?
    Foley J; Kirchhof P; Lip GY
    Curr Vasc Pharmacol; 2014 May; 12(3):373-83. PubMed ID: 24846226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation in atrial fibrillation: a new era has begun].
    Moser M; Bode C
    Hamostaseologie; 2012; 32(1):37-9. PubMed ID: 22124808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results.
    Pengo V; Crippa L; Falanga A; Finazzi G; Marongiu F; Moia M; Palareti G; Poli D; Testa S; Tiraferri E; Tosetto A; Tripodi A; Siragusa S; Manotti C
    J Thromb Haemost; 2012 Oct; 10(10):1979-87. PubMed ID: 22827490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care.
    Harris K; Mant J
    Int J Clin Pract; 2013 Jul; 67(7):647-55. PubMed ID: 23621153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
    Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.